New strategies for CNS injury and repair using stem cells, nanomedicine, neurotrophic factors and novel neuroprotective agents

Expert Review of Neurotherapeutics

Volumn 11, Issue 8, 2011, Pages 1121-1124

  Sharma, Hari Shanker ^a   Sharma, Aruna ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

blood brain barrier; brain trauma; cerebrolysin; neurodegenerative diseases; neurorepair; neurorestoratology; neurotrophic factors; spinal cord injury; stem cell therapy

Indexed keywords

NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR;

BRAIN INJURY; CONFERENCE PAPER; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; NANOMEDICINE; NERVE DEGENERATION; NEUROLOGY; NEUROPROTECTION; STEM CELL TRANSPLANTATION;

BRAIN INJURIES; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NANOMEDICINE; NERVE GROWTH FACTORS; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; STEM CELL TRANSPLANTATION; TRAUMA, NERVOUS SYSTEM;

EID: 79961098368     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.100     Document Type: Conference Paper

References (20)

1. Sharma HS. 4th Global College of Neuroprotection and Neuroregeneration Meeting. Expert Rev. Neurother. 7(6), 595-598 (2007). (Pubitemid 46911609)
2. Sharma HS. 10th International Conference on Amino Acids and Protein. Expert Rev. Neurother. 7(11), 1479-1484 (2007).
3. Sharma HS. 5th Annual Global College of Neuroprotection and Neuroregeneration. Expert Rev. Neurother. 8(6), 881-887 (2008). (Pubitemid 351872593)
4. Sharma HS, Sharma A. 6th Global College of Neuroprotection and Neuroregeneration, annual meeting. Expert Rev. Neurother. 9(7), 941-947 (2009).
5. Sharma HS, Sharma A. New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part I. Expert Rev. Neurother. 10(7), 1039-1043 (2010).
6. Sharma HS, Sharma A. New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part II. Expert Rev. Neurother. 10(8), 1253-1257 (2010).
7. Sharma HS, Sharma A. Conference scene: nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives. Nanomedicine 5(4), 533-537 (2010).
8. Raisman G, Carlstedt T, Choi D, Li Y. Clinical prospects for transplantation of OECs in the repair of brachial and lumbosacral plexus injuries: opening a door. Exp. Neurol. 229(1), 168-173 (2011).
9. Wu MM, Fan DG, Tadmori I et al. Death of axotomized retinal ganglion cells delayed after intraoptic nerve transplantation of olfactory ensheathing cells in adult rats. Cell Transplant. 19(2), 159-166 (2010).
10. Sharma HS, Ali S, Tian ZR et al. Nano-drug delivery and neuroprotection in spinal cord injury. J. Nanosci. Nanotechnol. 9(8), 5014-5037 (2009).
11. Sharma HS, Ali SF, Tian ZR et al. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. J. Nanosci. Nanotechnol. 9(8), 5073-5090 (2009).
12. Sharma HS, Patnaik R, Sharma A. Diabetes aggravates nanoparticles induced breakdown of the blood-brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J. Nanosci. Nanotechnol. 10(12), 7931-7945 (2010).
13. Huang H, Chen L, Sanberg P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med. 1(1), 15-46 (2010).
14. Muresanu DF, Sharma A, Sharma HS. Diabetes aggravates heat stress-induced blood-brain barrier breakdown, reduction in cerebral blood flow, edema formation, and brain pathology: possible neuroprotection with growth hormone. Ann. NY Acad. Sci. 1199, 15-26 (2010).
15. Sharma HS, Zimmermann-Meinzingen S, Johanson CE. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat. Ann. NY Acad. Sci. 1199, 125-137 (2010).
16. Menon PK. Effects of cerebrolysin, a mixture of neurotrophins on spinal cord injury in relation to nanoparticles treatment. Master's Thesis, Uppsala University, Uppsala, Sweden, 1-28 (2011).
17. Sharma HS. Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery. J. Neural Transm. 118(1), 3-6 (2011).
18. Sharma HS. Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection. J. Neural Transm. 118(1), 155-176 (2011).
19. Sharma HS, Muresanu DF, Sharma A, Patnaik R, Lafuente JV. Nanoparticles influence pathophysiology of spinal cord injury and repair. Prog. Brain Res. 180, 154-180 (2009).
20. Grünblatt E, Bartl J, Riederer P. The link between iron, metabolic syndrome, and Alzheimer's disease. J. Neural Transm. 118(3), 371-379 (2011).